Headline
The latest stories from AHA Today.
This week AONL issued an advocacy alert for measures in the $1.92 trillion COVID-19 stimulus package advanced by the House Committee on the Budget titled American Rescue Plan Act of 2021.
Preventing hospital acquired infections (HAIs) and antimicrobial resistance trends are the topic of an upcoming webinar hosted by the American Hospital Association’s Team Training initiative.
Futurist Ian Morrison, PhD, will lead Futurescan 2021-2026, a webinar for hospital and health system leaders exploring key forces and important insights gleaned by experts who contributed to the Society for Health Care Strategy & Market Development’s annual guide to trends in the field.
Last week, the Centers for Disease Control and Prevention (CDC) released guidance on treating extensively drug-resistant (XDR) Salmonella Typhi, which causes typhoid fever.
After recognizing high rates of airway complications among mechanically ventilated COVID-19 patients, a team at the University of Pennsylvania Health System, Philadelphia, devised the I-READI conceptual framework to help health care organizations respond to quality and safety challenges during…
The Department of Health and Human Services (HHS) announced actions to improve the availability of COVID-19 testing, including for schools and underserved populations; to increase domestic manufacturing of tests and testing supplies; and to better prepare the nation for the threat of variants by…
In response to the rising U.S. maternal mortality rate, this week the Joint Commission released Speak Up for New Parents, an educational campaign designed to help parents become aware of warning signs and symptoms that may indicate the need for medical help.
University of Washington (UW) researchers estimate the COVID-19 infection rate among pregnant women in Washington state to be 70% higher than in similarly aged adults, according to a study published this week in American Journal of Obstetrics and Gynecology.
In a United Kingdom study with more than 2,000 patients, Roche’s drug tocilizumab showed benefit for hospitalized COVID-19 patients with low oxygen levels and significant inflammation.
Millions of counterfeit 3M respirator masks are circulating in the United States, but the good news is, at least some of the masks appear to work.